Samsung Life Insurance (A032830) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Feb, 2026Executive summary
Consolidated net profit for FY2025 rose 9.3% year-over-year to KRW 2.3 trillion, a record high, driven by profit-focused operations and improved fundamentals.
Insurance service results reached KRW 975 billion, supported by high-margin health products and better management of operating variances.
Investment profit totaled KRW 2 trillion, maintained despite market volatility, with a focus on ALM and risk management.
Shareholders' equity increased to KRW 64.8 trillion, up KRW 26.7 trillion year-to-date, mainly due to net profit and gains from Samsung Electronics share price.
Financial highlights
Total assets stood at KRW 351 trillion as of December 2025, with KRW 247 trillion in invested assets.
Insurance liabilities were KRW 201 trillion, including KRW 184 trillion for BEL, KRW 3 trillion for RA, and KRW 13.2 trillion for CSM.
CSM balance at year-end was KRW 13.2 trillion, up KRW 0.3 trillion, driven by new business and actuarial adjustments.
Dividend per share for FY2025 was KRW 5,300, an 18% increase year-over-year.
Outlook and guidance
Targeting new business CSM of at least KRW 3.2 trillion in 2026, up from KRW 3.1 trillion in 2025.
Aiming for a new business CSM multiple of 12x in 2026, up from 11x in 2025.
Focus on sustainable growth in core insurance and asset management, with digital and healthcare ecosystem expansion.
Committed to a midterm shareholder return target of 50%.
Latest events from Samsung Life Insurance
- Net profit up 40.5% YoY to KRW 1,369bn, led by health segment and investment gains.A032830
Q2 20242 Feb 2026 - Q3 net profit up 41.6% YoY, led by health insurance and investment growth.A032830
Q3 202413 Jan 2026 - Record profit, robust capital, and higher dividends driven by health segment growth.A032830
Q4 20248 Jan 2026 - Net profit up 2.1% YoY to ₩635.3bn, health CSM at record high, K-ICS ratio stable at 180%.A032830
Q1 202527 Dec 2025 - H1 2025 net profit up 1.9% to KRW 1.394T, with improved CSM, KICS, and ESG rating AA.A032830
Q2 202523 Nov 2025 - Net profit up 3.7% YoY, with strong capital, robust health CSM, and higher equity.A032830
Q3 202513 Nov 2025